Arena Capital Advisors’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

Arena Capital Advisors’s Portfolio REVH Stock Details REVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,012,519	Closed	-$19.8M	–	228
2022 Q3	$19.8M	Hold	2,012,519	–	–	6%	2
2022 Q2	$19.7M	Sell	2,012,519 -196,410	-9%	-$1.92M	4.97%	2
2022 Q1	$21.7M	Sell	2,208,929 -269,733	-11%	-$2.63M	3.29%	3
2021 Q4	$24.1M	Sell	2,478,662 -620,226	-20%	-$6.06M	2.22%	4
2021 Q3	$30.1M	Buy	3,098,888 +2,348,881	+313%	+$22.9M	2.38%	2
2021 Q2	$7.37M	Buy	+750,007	New	+$7.39M	0.61%	50

Arena Capital Advisors's REVH Position: Q4 2022 in Review

Arena Capital Advisors sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 2,012,519 shares — an estimated $19.8M sold.

Arena Capital Advisors first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $30.1M in Q3 2021. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

Arena Capital Advisors reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Arena Capital Advisors sold 2,012,519 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $19.8M.
Arena Capital Advisors first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
Arena Capital Advisors's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $30.1M in Q3 2021.
0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on Arena Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.